Pr ecis: These findings suggest a rationale for personalized therapeutic management of non-small cell lung cancers, which harbor LKB1 mutations. 
Pr ecis: This study highlights clinically relevant roles for a cell surface immunosuppressive enzyme as a prognostic marker and candidate therapeutic target in ovarian cancer. Pr ecis: By revealing how a DNA mutator factor is upregulated in many human cancers, where it may contribute to pathogenesis and progression, this provocative study suggests new uses for PKC and NF-kB inhibitors in the neoadjuvant setting to decrease risks of acquired drug resistance and metastasis. Pr ecis: These findings offer insight into the development of oligodendocytes, a connective tissue cell in the central nervous system, and address the lack of preclinical models for a rare pediatric rhabdoid tumor arising from precursors of that cell lineage, known as atypical teratoid/rhabdoid tumors (AT/RT).
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